Stock Ticker

  • Loading stock data...

In Avanir Pharmaceuticals Inc (NASDAQ:AVNR)’s Rejected Drug Device, Analysts Hold A Different View

Boston, MA 11/27/2014 (wallstreetpr) – Avanir Pharmaceuticals Inc (NASDAQ:AVNR) suffered a blow this week when the U.S. Food and Drug Administration declined to approve its migraine drug device. The company had sought marketing approval for the device, which in many ways has good revenue promise. However, even though the FDA rejected the device, analysts believe that […]

United Parcel Service, Inc. (NYSE:UPS) Becomes The #58 Largest Company

Boston, MA 08/18/2014 (wallstreetpr) – According to reports, Eli Lilly & Co. (NYSE:LLY) has lost its place as the 58th largest company of the world. It has been replaced by a well known parcel service company United Parcel Service, Inc. (NYSE:UPS). Details: The Online Investor Inc. reported that on the basis of orders placed by […]

AbbVie Inc (NYSE:ABBV) And Abbott Laboratories (NYSE:ABT) To Face Consolidated Lawsuits In Chicago

Boston, MA 06/09/2014 (wallstreetpr) – AbbVie Inc (NYSE:ABBV) and Abbott Laboratories (NYSE:ABT) are alleged to hide risks associated with the testosterone substitute AndroGel. Both the Chicago based drug makers are to face lawsuits in a court in Chicago now while several cases over the same issue are already pending in the U.S. District Court. Judge […]

Top Three Trending Stocks: Alpha Natural Resources, Inc. (NYSE:ANR), Forest Laboratories, Inc. (NYSE:FRX), Eli Lilly & Co. (NYSE:LLY)

Boston, MA 02/20/2014 (wallstreetpr) – Alpha Natural Resources, Inc. (NYSE:ANR) last week had its stock price objective and rating by several investment analysts and brokerages tracking the company. Analysts at Barclays lowered their price target on the stock to $6 from $7 and planted and “equal-weight” rating. The stock also had its rating updated by JPMorgan […]

Most Active: American Realty Capital Properties Inc (NASDAQ:ARCP), Johnson & Johnson (NYSE:JNJ) And Eli Lilly & Co. (NYSE:LLY)

Boston, MA 02/19/2014 (wallstreetpr) – American Realty Capital Properties Inc (NASDAQ:ARCP) has reported that the company has now grown to be one of the most attractive services in the real estate investment sector. Of the several reasons for the company’s upside, one of the major include the Cole acquisition. This has proved to be worthy well […]

Pfizer Inc (NYSE:PFE) Among The Ten To Collaborate With The U.S. Government In Combating America’s Most Prevalent Diseases

Boston, MA 02/06/2014 (wallstreetpr) – Pfizer Inc (NYSE:PFE) is to work with the U.S. government to develop new treatments for some of the most prevalent diseases among Americans. In a $230 million project the government is trying to identify new cure for Alzheimer’s, diabetes, lupus and arthritis. In accordance with the practice of ‘groundbreaking’ at […]

The Stock Market Summary: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Valero Energy Corporation (NYSE:VLO), Regions Financial Corporation (NYSE:RF)

Boston, MA 02/06/2014 (wallstreetpr) – Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA): Talks about takeover bid of ARIA which dominated headlines over the past weeks, following a report on the Daily Mail, can now be put to rest as nothing of the sort can happen after the company disclosed executive stock giveaway in a SEC filing. In any […]

Eli Lilly & Co. (NYSE:LLY): Strong Product and Cost Cutting Lead To Better Earnings

Boston, MA 10/31/2013 (wallstreetpr) – Eli Lilly & Co. (NYSE:LLY) new strategy helped the company to raised better earnings than was expected by Wall Street. The two major components of this result was cost cutting and growth of a strong drug for depression, diabetes, and cancer. The company earned $1.20 million, or $1.11 per share, that […]

Testosterone- muscling its way towards fighting diabetes – LLY, ABBV, BAYN & BDX

Boston, MA 02/25/2013 (wallstreetpr) – Gary Wittert, professor of medicine in Australia at the University of Adelaide set out on a search for baby boomers last month, to participate in a clinical trial. One day is all it took to get him 800 volunteers for the trial of free testosterone injections. The professor and his […]

Sign Up To Get Our Latest Stocks Alerts